Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD.
Meier, Pascal
Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Apr 2011 - 697-9 p. digital
Publication Type: Editorial; Comment
1555-905X
10.2215/CJN.01490211 doi
Atherosclerosis--etiology
C-Reactive Protein--analysis
Cardiovascular Diseases--blood
Chronic Disease
Cytokine TWEAK
Endothelium, Vascular--physiopathology
Humans
Kidney Diseases--blood
Serum Amyloid P-Component--analysis
Tumor Necrosis Factors--blood
Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Apr 2011 - 697-9 p. digital
Publication Type: Editorial; Comment
1555-905X
10.2215/CJN.01490211 doi
Atherosclerosis--etiology
C-Reactive Protein--analysis
Cardiovascular Diseases--blood
Chronic Disease
Cytokine TWEAK
Endothelium, Vascular--physiopathology
Humans
Kidney Diseases--blood
Serum Amyloid P-Component--analysis
Tumor Necrosis Factors--blood